These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37341495)

  • 21. Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice.
    Pizzorno A; Abed Y; Plante PL; Carbonneau J; Baz M; Hamelin MÈ; Corbeil J; Boivin G
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6398-405. PubMed ID: 25114143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir.
    Tamura D; DeBiasi RL; Okomo-Adhiambo M; Mishin VP; Campbell AP; Loechelt B; Wiedermann BL; Fry AM; Gubareva LV
    J Infect Dis; 2015 Oct; 212(8):1209-13. PubMed ID: 25943200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus susceptibility and clinical effectiveness of anti-influenza drugs during the 2010-2011 influenza season in Russia.
    Leneva IA; Burtseva EI; Yatsyshina SB; Fedyakina IT; Kirillova ES; Selkova EP; Osipova E; Maleev VV
    Int J Infect Dis; 2016 Feb; 43():77-84. PubMed ID: 26775570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors.
    Tamura D; Sugaya N; Ozawa M; Takano R; Ichikawa M; Yamazaki M; Kawakami C; Shimizu H; Uehara R; Kiso M; Kawakami E; Mitamura K; Kawaoka Y
    Clin Infect Dis; 2011 Feb; 52(4):432-7. PubMed ID: 21248368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oseltamivir-resistant pandemic (H1N1) 2009 virus, South Korea.
    Yi H; Lee JY; Hong EH; Kim MS; Kwon D; Choi JH; Choi WY; Kim KS; Lee JK; Oh HB; Kang C
    Emerg Infect Dis; 2010 Dec; 16(12):1938-42. PubMed ID: 21122225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammalian pathogenesis of oseltamivir-resistant pandemic (H1N1) 2009 influenza virus isolated in South Korea.
    Kwon D; Shin K; Kim SJ; Lee JY; Kang C
    Virus Res; 2014 Jun; 185():41-6. PubMed ID: 24657788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.
    Ranadheera C; Hagan MW; Leung A; Collignon B; Cutts T; Theriault S; Embury-Hyatt C; Kobasa D
    J Virol; 2016 Nov; 90(21):9931-9941. PubMed ID: 27558428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of epidemic viruses to neuraminidase inhibitors and treatment-emergent resistance in the Japanese 2019-20 influenza season.
    Tani N; Kawai N; Chong Y; Bando T; Iwaki N; Kashiwagi S; Ikematsu H
    J Infect; 2022 Feb; 84(2):151-157. PubMed ID: 34861350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza viruses resistant to neuraminidase inhibitors.
    Nitsch-Osuch A; Brydak LB
    Acta Biochim Pol; 2014; 61(3):505-8. PubMed ID: 25195142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic.
    Dixit R; Khandaker G; Ilgoutz S; Rashid H; Booy R
    Infect Disord Drug Targets; 2013 Feb; 13(1):34-45. PubMed ID: 23675925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmission.
    Ghedin E; Holmes EC; DePasse JV; Pinilla LT; Fitch A; Hamelin ME; Papenburg J; Boivin G
    J Infect Dis; 2012 Nov; 206(10):1504-11. PubMed ID: 22966122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages.
    Janies DA; Voronkin IO; Studer J; Hardman J; Alexandrov BB; Treseder TW; Valson C
    Int J Health Geogr; 2010 Feb; 9():13. PubMed ID: 20181276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory Activity of Honeysuckle Extracts against Influenza A Virus In Vitro and In Vivo.
    Li M; Wang Y; Jin J; Dou J; Guo Q; Ke X; Zhou C; Guo M
    Virol Sin; 2021 Jun; 36(3):490-500. PubMed ID: 33044658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
    Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J
    Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.
    Marjuki H; Mishin VP; Chesnokov AP; Jones J; De La Cruz JA; Sleeman K; Tamura D; Nguyen HT; Wu HS; Chang FY; Liu MT; Fry AM; Cox NJ; Villanueva JM; Davis CT; Gubareva LV
    J Infect Dis; 2015 Jan; 211(2):249-57. PubMed ID: 25124927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients.
    Couturier BA; Bender JM; Schwarz MA; Pavia AT; Hanson KE; She RC
    Influenza Other Respir Viruses; 2010 Jul; 4(4):199-204. PubMed ID: 20836794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.
    Hurt AC; Nor'e SS; McCaw JM; Fryer HR; Mosse J; McLean AR; Barr IG
    J Virol; 2010 Sep; 84(18):9427-38. PubMed ID: 20631138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oseltamivir Resistance in Severe Influenza A(H1N1)pdm09 Pneumonia and Acute Respiratory Distress Syndrome: A French Multicenter Observational Cohort Study.
    Behillil S; May F; Fourati S; Luyt CE; Chicheportiche T; Sonneville R; Tandjaoui-Lambiotte Y; Roux D; Guérin L; Mayaux J; Maury E; Ferré A; Georger JF; Voiriot G; Enouf V; van der Werf S; Dessap AM; de Prost N
    Clin Infect Dis; 2020 Aug; 71(4):1089-1091. PubMed ID: 31538643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.